The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Targeting the Lactate Transporter MCT1 in Endothelial Cells Inhibits Lactate-Induced HIF-1 Activation and Tumor Angiogenesis
Open accessAbstract
Switching to a glycolytic metabolism is a rapid adaptation of tumor cells to hypoxia. Although this metabolic conversion may primarily represent a rescue pathway to meet the bioenergetic and biosynthetic demands of proliferating tumor cells, it also creates a gradient of lactate that mirrors the gradient of oxygen in tumors. More than a metabolic waste, the lactate anion is known to participate to cancer aggressiveness, in part through activation of the hypoxia-inducible factor-1 (HIF-1) pathway in tumor cells. Whether lactate may also directly favor HIF-1 activation in endothelial cells (ECs) thereby offering a new druggable option to block angiogenesis is however an unanswered question. In this study, we therefore focused on the role in ECs of monocarboxylate transporter 1 (MCT1) that we previously identified to be the main facilitator of lactate uptake in cancer cells. We found that blockade of lactate influx into ECs led to inhibition of HIF-1-dependent angiogenesis. Our demonstration is based on the unprecedented characterization of lactate-induced HIF-1 activation in normoxic ECs and the consecutive increase in vascular endothelial growth factor receptor 2 (VEGFR2) and basic fibroblast growth factor (bFGF) expression. Furthermore, using a variety of functional assays including endothelial cell migration and tubulogenesis together with in vivo imaging of tumor angiogenesis through intravital microscopy and immunohistochemistry, we documented that MCT1 blockers could act as bona fide HIF-1 inhibitors leading to anti-angiogenic effects. Together with the previous demonstration of MCT1 being a key regulator of lactate exchange between tumor cells, the current study identifies MCT1 inhibition as a therapeutic modality combining antimetabolic and anti-angiogenic activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, lactate accumulation is instrumental for the promotion of angiogenesis.”
From The emerging hallmarks of cancer metabolism (2016) · cites this paper as Sonveaux et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717 · cited 1×
“transporter 4 (MCT4) and key pro-angiogenic effectors such as vascular endothelial growth factor (VEGF) [11,12].”
BackgroundThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981
Regulation of angiogenesis by hypoxia: role of the HIF system
Pugh, C. W., & Ratcliffe, P. J. (2003) · Nature Medicine · doi:10.1038/nm0603-677 · Cited by 2,520
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 2,011
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 541
Mu, X., Zhao, T., Xu, C., Shi, W., Geng, B., Shen, J., Zhang, C., Pan, J., Yang, J., Hu, S., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14485 · Cited by 124
Draoui, N., Schicke, O., Seront, E., Bouzin, C., Sonveaux, P., Riant, O., & Féron, O. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0653 · Cited by 124
Self-citationStalling the Engine of Resistance: Targeting Cancer Metabolism to Overcome Therapeutic Resistance
Butler, E. B., Zhao, Y., Muñoz‐Pinedo, C., Lu, J., & Tan, M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3009 · Cited by 126
Feedback regulation of ALDOA activates the HIF-1α/MMP9 axis to promote lung cancer progression
Chang, Y., Chan, Y.-C., Chang, W., Lin, Y., Yang, C., Su, C., Huang, M.-S., Wu, A. T. H., & Hsiao, M. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.001 · Cited by 123
The function and mechanism of lactate and lactylation in tumor metabolism and microenvironment
Zhang, Y., Peng, Q., Zheng, J., Yang, Y., Zhang, X., Ma, A., Qin, Y., Qin, Z., & Xiang, Z. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.10.006 · Cited by 133
Kitamura, F., Semba, T., Yasuda-Yoshihara, N., Yamada, K., Nishimura, A., Yamasaki, J., Nagano, O., Yasuda, T., Yonemura, A., Tong, Y., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.163022 · Cited by 121
“Given that lactate is 346 involved in cancer progression(38) by affecting the TME, such as by promoting 347 angiogenesis(39, 40) and suppressing antitumor immunity(31, 41), we sought to 348 elucidate the tumor-promoting roles of lactate in the PDAC TME.”
BackgroundThe Warburg effect: a score for many instruments in the concert of cancer and cancer niche cells
Jaworska, M., Szczudło, J., Pietrzyk, A., Shah, J., Trojan, S., Ostrowska, B., & Kocemba‐Pilarczyk, K. A. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00504-1 · Cited by 128
Deep, G., & Panigrahi, G. (2015) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v20.i5-6.130 · Cited by 121
Zhao, L., Liu, Y., Zhang, S., Wei, L., Cheng, H., Wang, J., & Wang, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04821-w · Cited by 115
Puri, S., & Juvale, K. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112393 · Cited by 115
Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions
Gantuya, B., El‐Serag, H. B., Matsumoto, T., Ajami, N. J., Uchida, T., Oyuntsetseg, K., Bolor, D., & Yamaoka, Y. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15675 · Cited by 109
Cancer: fundamentals behind pH targeting and the double-edged approach
Koltai, T. (2016) · OncoTargets and Therapy · doi:10.2147/ott.s115438 · Cited by 110
Lactic Acid: A Novel Signaling Molecule in Early Pregnancy?
Ma, L., Huang, X., Muyayalo, K. P., Mor, G., & Liao, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00279 · Cited by 109
Saedeleer, C. J. D., Porporato, P. E., Copetti, T., Pérez‐Escuredo, J., Payen, V. L., Brisson, L., Féron, O., & Sonveaux, P. (2013) · Oncogene · doi:10.1038/onc.2013.454 · Cited by 105
Self-citationRadiation induces senescence and a bystander effect through metabolic alterations
Liao, E.-C., Hsu, Y.-T., Chuah, Q.-Y., Lee, Y. J., Hu, J.-Y., Huang, T.-C., Yang, P., & Chiu, S.-J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.220 · Cited by 106
Hyperbaric Oxygen, Vasculogenic Stem Cells, and Wound Healing
Fosen, K. M., & Thom, S. R. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5940 · Cited by 104
Sun, X., He, L., Liu, H., Thorne, R. F., Zeng, T., Liu, L., Zhang, B., He, M., Huang, Y., Li, M., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.07.005 · Cited by 105
Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Cancers · doi:10.3390/cancers13215557 · Cited by 101
Judson, I. R., Morden, J. P., Kilburn, L., Leahy, M. G., Benson, C., Bhadri, V. A., Campbell‐Hewson, Q., Cubedo, R., Dangoor, A., Fox, L., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30215-3 · Cited by 98
Targeting lactate-related cell cycle activities for cancer therapy
Lin, J. L., Liu, G., Chen, L., Kwok, H. F., & Lin, Y. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.10.009 · Cited by 101
Paolini, L., Adam, C., Beauvillain, C., Preisser, L., Blanchard, S., Pignon, P., Seegers, V., Chevalier, L.-M., Campone, M., Wernert, R., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0749 · Cited by 103
Kozlov, A. M., Lone, A., Betts, D. H., & Cumming, R. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-65193-9 · Cited by 94
Extracellular Acid-Base Balance and Ion Transport Between Body Fluid Compartments
Seifter, J. L., & Chang, H.-Y. (2017) · Physiology · doi:10.1152/physiol.00007.2017 · Cited by 95
San-Millán, I., Julian, C. G., Matarazzo, C. J., Martinez, J. L., & Brooks, G. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01536 · Cited by 93
Endothelial Cell Glucose Metabolism and Angiogenesis
Du, W., Ren, L., Hamblin, M. H., & Fan, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9020147 · Cited by 92
Ocaña, M. C., Martı́nez-Poveda, B., Quesada, A. R., & Medina, M. Á. (2018) · Medicinal Research Reviews · doi:10.1002/med.21511 · Cited by 92
Tumor metabolism, cancer cell transporters, and microenvironmental resistance
Alfarouk, K. O. (2016) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2016.1140753 · Cited by 88
Yan, W., Xu, H., Dai, J., Peng, J., Wang, W., Xia, L., & Zhou, F. (2018) · BioMed Research International · doi:10.1155/2018/1804086 · Cited by 87
Cell Metabolism and DNA Repair Pathways: Implications for Cancer Therapy
Sobanski, T., Rose, M., Suraweera, A., O'Byrne, K. J., Richard, D. J., & Bolderson, E. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.633305 · Cited by 86
Zhang, X., Ashcraft, K. A., Warner, A. B., Nair, S. K., & Dewhirst, M. W. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2468 · Cited by 89
Self-citationLactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis
Guyon, J., Fernández‐Moncada, I., Larrieu, C. M., Bouchez, C. L., Zottola, A. C. P., Galvis, J., Chouleur, T., Burban, A., Joseph, K., Ravi, V. M., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202115343 · Cited by 90
Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
Eilertsen, M., Andersen, S., Al‐Saad, S., Kiselev, Y., Dønnem, T., Stenvold, H., Pettersen, I., Al-Shibli, K. I., Richardsen, E. H., Busund, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105038 · Cited by 84
Lactate transporters as therapeutic targets in cancer and inflammatory diseases
Pucino, V., Cucchi, D., & Mauro, C. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1511706 · Cited by 87
Jin, M., Cao, W., Chen, B., Xiong, M., & Cao, G. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.808859 · Cited by 88
Chaube, B., Malvi, P., Singh, S. V., Mohammad, N., Meena, A. S., & Bhat, M. K. (2015) · Oncotarget · doi:10.18632/oncotarget.6134 · Cited by 80
Berrios, C. J., Padi, M., Keibler, M. A., Park, D. E., Vadim, M., Cheng, J., Lee, S. M., Stephanopoulos, G. N., Quackenbush, J. F., & DeCaprio, J. A. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006020 · Cited by 79
Lemma, S., Pompo, G. D., Porporato, P. E., Sboarina, M., Russell, S., Gillies, R. J., Baldini, N., Sonveaux, P., & Avnet, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.030 · Cited by 80
Self-citationGlycolysis-mediated control of blood-brain barrier development and function
Salmina, A. B., Kuvacheva, N. V., Morgun, A. V., Komleva, Y. K., Пожиленкова, Е. А., Lopatina, O. L., Gorina, Y. V., Таранушенко, Т. Е., & Petrova, L. L. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.04.005 · Cited by 76
Hypoxia optimises tumour growth by controlling nutrient import and acidic metabolite export
Parks, S. K., Cormerais, Y., Marchiq, I., & Pouysségur, J. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.12.001 · Cited by 80
Gómez, V., Eykyn, T. R., Mustapha, R., Flores‐Borja, F., Male, V. H., Barber, P. R., Patsialou, A., Green, R. J., Panagaki, F., Li, C. W., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aax4585 · Cited by 77
Estrogen receptor‐β in mitochondria: implications for mitochondrial bioenergetics and tumorigenesis
Liao, T.-L., Tzeng, C., Yu, C., Wang, Y., & Kao, S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12872 · Cited by 78
Lactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization
Song, J., Lee, K., Park, S. W., Chung, H., Jung, D., Na, Y. R., Quan, H., Cho, C. S., Che, J., Kim, J. H., et al. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-23892 · Cited by 76
Fibroblast Growth Factor Receptor Signaling in Skin Cancers
Czyż, M. (2019) · Cells · doi:10.3390/cells8060540 · Cited by 74
Blatt, S., Voelxen, N., Sagheb, K., Pabst, A. M., Walenta, S., Schroeder, T., Mueller‐Klieser, W., & Ziebart, T. (2016) · Clinical Oral Investigations · doi:10.1007/s00784-015-1699-6 · Cited by 79
The Immune Consequences of Lactate in the Tumor Microenvironment
Harmon, C., O’Farrelly, C., & Robinson, M. W. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-43093-1_7 · Cited by 73
Tao, H., Zhong, X., Zeng, A., & Song, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1208870 · Cited by 77
How glucose, glutamine and fatty acid metabolism shape blood and lymph vessel development
Teuwen, L.-A. M. N., Geldhof, V., & Carmeliet, P. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.12.001 · Cited by 75
PLGA: From a classic drug carrier to a novel therapeutic activity contributor
Chereddy, K. K., Payen, V. L., & Véronique Préat, A. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.017 · Cited by 75
Endothelial cell metabolism and implications for cancer therapy
Harjes, U., Bensaad, K., & Harris, A. L. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.398 · Cited by 72
Draoui, N., Schicke, O., Fernandes, A. E., Drozak, X., Nahra, F., Dumont, A. O., Douxfils, J., Hermans, E., Dogné, J., Corbau, R., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.09.010 · Cited by 72
Self-citationTargeting tumor-associated acidity in cancer immunotherapy
Lacroix, R., Rozeman, E. A., Kreutz, M. P., Renner, K., & Blank, C. U. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2195-z · Cited by 71
Singh, L., Nair, L. S., Kumar, D., Arora, M. K., Bajaj, S., Gadewar, M. M., Mishra, S. S., Rath, S. K., Dubey, A. K., Kaithwas, G., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1034205 · Cited by 73
Endogenous and Exogenous Antioxidants in Skeletal Muscle Fatigue Development during Exercise
Supruniuk, E., Górski, J., & Chabowski, A. (2023) · Antioxidants · doi:10.3390/antiox12020501 · Cited by 72
Targeting the lactic acid metabolic pathway for antitumor therapy
Li, Z., & Cui, J. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100740 · Cited by 72
The metabolic cooperation between cells in solid cancer tumors
Icard, P., Kafara, P., Steyaert, J., Schwartz, L. H., & Lincet, H. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.06.002 · Cited by 74
Control of vessel sprouting by genetic and metabolic determinants
Eelen, G., Cruys, B., Welti, J. C., Bock, K. D., & Carmeliet, P. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.08.006 · Cited by 73
Danhier, F., Danhier, P., Saedeleer, C. J. D., Fruytier, A., Schleich, N., Rieux, A. D., Sonveaux, P., Gallez, B., & Véronique Préat, A. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.009 · Cited by 68
Self-citationAnnan, D. A., Maishi, N., Soga, T., Dawood, R., Li, C., Kikuchi, H., Hojo, T., Morimoto, M., Kitamura, T., Alam, M. T., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0478-4 · Cited by 67
Blood-brain barrier-supported neurogenesis in healthy and diseased brain
Пожиленкова, Е. А., Lopatina, O. L., Komleva, Y. K., Salmin, V. V., & Salmina, A. B. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0071 · Cited by 66
Wu, D., Harrison, D. L., Szasz, T., Yeh, C., Shentu, T., Meliton, A. Y., Huang, R., Zhou, Z., Mutlu, G. M., Huang, J., et al. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00390-y · Cited by 68
Oral microbiota and Helicobacter pylori in gastric carcinogenesis: what do we know and where next?
Bakhti, S. Z., & Latifi‐Navid, S. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02130-4 · Cited by 68
Liu, T., Han, S., Yao, Y., & Zhang, G. (2023) · Cancer Management and Research · doi:10.2147/cmar.s421771 · Cited by 65
Huang, A., Sun, Z., Hong, H., Yang, Y., Chen, J., Gao, Z., & Gu, J. F. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05391-5 · Cited by 66
Metabolic regulation of exercise-induced angiogenesis
Gorski, T., & Bock, K. D. (2019) · Vascular Biology · doi:10.1530/vb-19-0008 · Cited by 64
Lactate shuttle: from substance exchange to regulatory mechanism
Wang, X. T., Liu, H., Ni, Y., Shen, P., & Han, X. (2021) · Human Cell · doi:10.1007/s13577-021-00622-z · Cited by 63
Ma, X., Jia, Y., Zu, S., Li, R., Jia, Y., Zhao, Y., Xiao, D., Dang, N., & Wang, Y. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.023 · Cited by 66
Zhang, X., Wu, Y. R., Pan, Z., Sun, H., Wang, J., Yu, D., Zhu, S., Dai, J., Chen, Y., Tian, N., et al. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.06.029 · Cited by 63
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Bernhard, C., Reita, D., Martin, S., Entz‐Werlé, N., & Dontenwill, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119137 · Cited by 66
Protective effects of L-theanine against doxorubicin-induced nephrotoxicity in rats
Altınkaynak, Y., Kural, B. V., Akçan, B., Bodur, A., Özer, S., Yuluğ, E., Munğan, S., Kaya, C., & Örem, A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.171 · Cited by 62
NF-κB and mitochondria cross paths in cancer: mitochondrial metabolism and beyond
Capece, D., Verzella, D., Francesco, B. D., Alesse, E., Franzoso, G., & Zazzeroni, F. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.021 · Cited by 66
Zalpoor, H., Aziziyan, F., Liaghat, M., Bakhtiyari, M., Akbari, A., Nabi‐Afjadi, M., Forghaniesfidvajani, R., & Rezaei, N. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00951-y · Cited by 63
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
Chapiro, J., Sur, S., Savic, L. J., Ganapathy‐Kanniappan, S., Reyes, J., Durán, R., Chettiar, S. T., Moats, C. R., Lin, M., Luo, W., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1271 · Cited by 63
Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect
Pereira‐Nunes, A., Afonso, J., Granja, S., & Baltazar, F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_3 · Cited by 63
Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance
Dratkiewicz, E., Simiczyjew, A., Mazurkiewicz, J., Ziętek, M., Matkowski, R., & Nowak, D. (2021) · Cells · doi:10.3390/cells10040862 · Cited by 65
Zhou, J., Shrestha, P., Qiu, Z. G., Harman, D. G., Teoh, W.-C., Al‐Sohaily, S., Liem, H., Turner, I. B., & Ho, V. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072162 · Cited by 60
Microbiota and metabolites alterations in proximal and distal gastric cancer patients
Yang, Y., Dai, D., Jin, W. Y., Huang, Y., Zhang, Y., Chen, Y., Wang, W., Wu, L., Chen, X., Zhang, J., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03650-x · Cited by 60
Targeting lactate metabolism and immune interaction in breast tumor via protease-triggered delivery
Zhao, P., Wang, S., Jiang, J., Gao, Y., Wang, Y., Zhao, Y., Zhang, J., Zhang, M., & Huang, Y. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.05.024 · Cited by 61
Ullmann, P., Qureshi-Baig, K., Rodriguez, F., Ginolhac, A., Nonnenmacher, Y., Ternes, D., Weiler, J., Gäbler, K., Bahlawane, C., Hiller, K., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11772 · Cited by 60
Lactate induces FGF21 expression in adipocytes through a p38-MAPK pathway
Jeanson, Y., Ribas‐Aulinas, F., Galinier, A., Arnaud, E., Ducos, M., André, M., Chenouard, V., Villarroya, F., Casteilla, L., & Carrière, A. (2016) · Biochemical Journal · doi:10.1042/bj20150808 · Cited by 59
Benyahia, Z., Blackman, M. C. N. M., Hamelin, L., Zampieri, L. X., Capelôa, T., Bedin, M., Vazeille, T., Schakman, O., & Sonveaux, P. (2021) · Cancers · doi:10.3390/cancers13030569 · Cited by 58
Self-citationTumor lactic acid: a potential target for cancer therapy
Byun, J. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01431-8 · Cited by 58
A comparison of exogenous and endogenous CEST MRI methods for evaluating in vivo p H
Lindeman, L. R., Randtke, E. A., High, R. A., Jones, K. M., Howison, C. M., & Pagel, M. D. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26924 · Cited by 57
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Reuss, A. M., Groos, D., Buchfelder, M., & Savaskan, N. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115518 · Cited by 58
The application and research progress of anti-angiogenesis therapy in tumor immunotherapy
Tu, J., Liang, H., Li, C., Huang, Y., Wang, Z., Chen, X., & Yuan, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1198972 · Cited by 53
Lactate: a rising star in tumors and inflammation
Liu, H., Pan, M., Liu, M., Zeng, L., Li, Y., Huang, Z., Guo, C., & Wang, H. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1496390 · Cited by 60
Common Responses of Tumors and Wounds to Hypoxia
Payen, V. L., Brisson, L., Dewhirst, M. W., & Sonveaux, P. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000098 · Cited by 55
Self-citationDroplet Microfluidic Platform for the Determination of Single-Cell Lactate Release
Mongersun, A., Smeenk, I., Pratx, G., Asuri, P., & Abbyad, P. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b04681 · Cited by 56
Zhou, Y., Tong, F., Gu, W., He, S., Yang, X., Li, J., Gao, Y., & Gao, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.001 · Cited by 52
Suppression of myeloid PFKFB3‐driven glycolysis protects mice from choroidal neovascularization
Liu, Z., Mao, X., Yang, Q., Zhang, X., Xu, J., Ma, Q., Zhou, Y., Da, Q., Cai, Y., Sopeyin, A., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15925 · Cited by 52
pH regulators and their inhibitors in tumor microenvironment
Liao, S., Wu, G., Xie, Z., Lei, X., Yang, X., Huang, S., Deng, X., Wang, Z., & Tang, G. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116170 · Cited by 52
Metabolic Regulation of Angiogenesis in Diabetes and Aging
Sawada, N., & Arany, Z. P. (2017) · Physiology · doi:10.1152/physiol.00039.2016 · Cited by 55
Certo, M., Elkafrawy, H., Pucino, V., Cucchi, D., Cheung, K. C.-P., & Mauro, C. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15002 · Cited by 54
Targeting glycolysis for cancer therapy using drug delivery systems
Huang, Y. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.003 · Cited by 51
Monocarboxylate Transporter 1 Inhibitors as Potential Anticancer Agents
Jonnalagadda, S., Jonnalagadda, S. K., Alam, M. A., Nelson, G. L., Sneve, M., Drewes, L. R., & Mereddy, V. R. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5b00049 · Cited by 51
Miranda‐Gonçalves, V., Gonçalves, C. S., Granja, S., de Castro, J. V., Reis, R. M., Costa, B. M., & Baltazar, F. (2021) · Cancers · doi:10.3390/cancers13143468 · Cited by 50
Gurner, K. H., Evans, J., Hutchison, J. C., Harvey, A. J., & Gardner, D. K. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.09.012 · Cited by 51
Targeting of stress response pathways in the prevention and treatment of cancer
Zelenka, J., Koncošová, M., & Ruml, T. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.01.007 · Cited by 50
Regulation of Autophagy via Carbohydrate and Lipid Metabolism in Cancer
Alizadeh, J., Kavoosi, M., Singh, N., Lorzadeh, S., Ravandi, A., Kidane, B., Ahmed, N., Mraiche, F., Mowat, M. R. A., & Ghavami, S. (2023) · Cancers · doi:10.3390/cancers15082195 · Cited by 51
Treps, L., Conradi, L., Harjes, U., & Carmeliet, P. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012492 · Cited by 52
Tang, Y., Jia, C., Wang, Y., Wan, W., Li, H., Huang, G., & Zhang, X. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202100799 · Cited by 49
Metadata
- Authors
- Sonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., Gallez, B., Ribeiro, A., Michiels, C., Dewhirst, M. W., & Feron, O.
- Affiliations
- Duke Medical Center (US)
- UCLouvain (BE)
- Duke University (US)
- University of Namur (BE)
- Corresponding author
- Sonveaux, Pierre
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-03-13
- Volume
- 7
- Issue
- 3
- Pages
- e33418
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3302812
- OpenAlex
- W2003842905
- Cited by
- 536
- References
- 67
- Citations by year
- 2026: 34 · 2025: 38 · 2024: 25 · 2023: 50 · 2022: 58 · 2021: 46 · 2020: 62 · 2019: 34 · 2018: 36 · 2017: 36 · 2016: 30 · 2015: 32 · 2014: 26 · 2013: 22 · 2012: 6
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Repository of the University of Namur (submittedVersion, other-oa)
- Funders
- Belgian American Educational Foundation
- Fonds De La Recherche Scientifique - FNRS
- National Institutes of Health (FP7/2007-2013, 5p01ca042745-23)
- National Cancer Institute (CA40355, R01CA040355, CA40355-24, P01-CA042745, CA40355-25)
- FP7 Ideas: European Research Council (243188)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- MCT1, MCT1 inhibition, lactate transport, endothelial cells, tumor angiogenesis, tumor hypoxia, glycolytic metabolism, VEGFR2, basic fibroblast growth factor, anti-angiogenic therapy, tumor microenvironment
- MeSH terms
- Monocarboxylate Transport Protein 1, Analysis of Variance, Animals, Cell Movement, Enzyme-Linked Immunosorbent Assay, Fibroblast Growth Factors, Humans, Immunohistochemistry, Luciferases, Neoplasms, Neovascularization, Pathologic, Blotting, Western, Polymerase Chain Reaction, Lactic Acid, Nuclear Magnetic Resonance, Biomolecular, Monocarboxylic Acid Transporters, Symporters, RNA Interference, RNA, Small Interfering, Vascular Endothelial Growth Factor Receptor-2, Endothelial Cells, Mice, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
